by Luca Barattini | Feb 6, 2023 | Clinical Trial:, Insights
Panin (Italy) starts two new clinical trial in Europe 06/02/2023 PANIN, an Italian-based pharmaceutical company, announces the starting of two new clinical trials in East Europe handled by Opera CRO. The tested products are vaginal suppositories for vaginal dryness...
by Luca Barattini | Jan 20, 2023 | Clinical Trial:, Insights
SIIT and Opera CRO: 20/01/2023 SIIT, an Italian company manufacturing innovative healthcare products, announced that the planning, execution, and analysis of its new clinical trial in recurrent bacterial vaginosis will be performed by the contract research...
by Luca Barattini | Dec 18, 2022 | Clinical Trial:, Insights
Nausea and vomiting in pregnant women: an Italian survey (PURITY) 18/12/2022 The interim analysis of the survey “Prevalence and burden of nausea and vomiting in pregnant women. An Italian Survey (PURITY)” was presented at the National Congress...
by admin | Oct 18, 2022 | Clinical Trial:, Insights
Press releases Canopus Medical AB has contracted OPERA CRO to conduct its clinical trials in Europe Canopus Medical AB today announced that the company has entered an agreement for clinical services with the global contract research organization Opera CRO, for the...
by Luca Barattini | Sep 15, 2022 | Clinical Trial:
Polybactum® to Assess Recurrent Bacterial Vaginosis Study results! 15/09/2022 We are pleased to announce the conclusion of the clinical trial with 10-month follow-up “Polybactum® to Assess Recurrent Bacterial Vaginosis (Polaris)”. The manuscript...
